Tenax Therapeutics (TENX) Price to Earnings (2010 - 2026)

Tenax Therapeutics has disclosed Price to Earnings across 17 years of filings, most recently posting 36.96 for Q2 2026.

• In Q2 2026, Price to Earnings fell 75.75% year-over-year to 36.96; the TTM figure through Jun 2026 stood at 10.15 (down 40.15% YoY), while the FY2025 annual figure was 9.09, down 69.35% from the prior year.
• Price to Earnings came in at 36.96 for Q2 2026 at Tenax Therapeutics, up from 46.03 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 291.03 in Q3 2023 to a low of 600.18 in Q1 2022.
• Average Price to Earnings over 5 years is 46.29, with a median of 18.82 recorded in 2024.
• Year-over-year, Price to Earnings soared 471.89% in 2022 and slumped 3288.45% in 2024.
• Over 5 years, Price to Earnings stood at 102.29 in 2022, then sank by 100.44% to 0.45 in 2023, then tumbled by 3288.45% to 15.08 in 2024, then slumped by 104.06% to 30.78 in 2025, then declined by 20.08% to 36.96 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 36.96 in Q2 2026, 46.03 in Q1 2026, and 30.78 in Q4 2025.